Clinical Trial Update: Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-17

View source ↗

Summary

A companion protocol update for a methacetin breath test in the Meridian Bioscience study (NCT03462576) related to decompensated cirrhosis; the trial status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Cirrhosis

Drugs mentioned

• Methacetin Breath Test (methacetin breath test)

Snippet

Sponsor: Meridian Bioscience, Inc. | Conditions: Decompensated Cirrhosis | Status: TERMINATED | Results posted: 2020-12-16